{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:47:11Z","timestamp":1790214431332,"version":"4.1.0"},"reference-count":131,"publisher":"Baishideng Publishing Group Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Methodol"],"abstract":"<jats:p>The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) belongs to the genus Beta coronavirus and the family of Coronaviridae. It is a positive-sense, non-segmented single-strand RNA virus. Four common types of human coronaviruses circulate globally, particularly in the fall and winter seasons. They are responsible for 10%-30% of all mild upper respiratory tract infections in adults. These are 229E, NL63 of the Alfacoronaviridae family, OC43, and HKU1 of the Betacoronaviridae family. However, there are three highly pathogenic human coronaviruses: SARS-CoV-2, Middle East respiratory syndrome coronavirus, and the latest pandemic caused by the SARS-CoV-2 infection. All viruses, including SARS-CoV-2, have the inherent tendency to evolve. SARS-CoV-2 is still evolving in humans. Additionally, due to the development of herd immunity, prior infection, use of medication, vaccination, and antibodies, the viruses are facing immune pressure. During the replication process and due to immune pressure, the virus may undergo mutations. Several SARS-CoV-2 variants, including the variants of concern (VOCs), such as B.1.1.7 (Alpha), B.1.351 (Beta), B.1.617\/ B.1.617.2 (Delta), P.1 (Gamma), and B.1.1.529 (Omicron) have been reported from various parts of the world. These VOCs contain several important mutations; some of them are on the spike proteins. These mutations may lead to enhanced infectivity, transmissibility, and decreased neutralization efficacy by monoclonal antibodies, convalescent sera, or vaccines. Mutations may also lead to a failure of detection by molecular diagnostic tests, leading to a delayed diagnosis, increased community spread, and delayed treatment. We searched PubMed, EMBASE, Covariant, the Stanford variant Database, and the CINAHL from December 2019 to February 2023 using the following search terms: VOC, SARS-CoV-2, Omicron, mutations in SARS-CoV-2, etc.  This review discusses the various mutations and their impact on infectivity, transmissibility, and neutralization efficacy.<\/jats:p>","DOI":"10.5662\/wjm.v14.i3.89761","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T02:10:56Z","timestamp":1719281456000},"source":"Crossref","is-referenced-by-count":16,"title":["COVID-19 mutations: An overview"],"prefix":"10.5662","volume":"14","author":[{"given":"Malay","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irappa","family":"Madabhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"B1","unstructured":"Coronavirus Mutations and Variants: What Does It Mean? Available from: https:\/\/srhd.org\/news\/2021\/coronavirus-mutations-and-variants-what-does-it-mean"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2299-6"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-020-02544-6"},{"key":"B4","unstructured":"Ashley Hagen, M.   S. Is the Science Communications Specialist at the American Society for Microbiology. Available from: https:\/\/asm.org\/Biographies\/Ashley-Hagen"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0508200103"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4161\/rna.8.2.15013"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01394-09"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009226"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.08.014"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00408-20"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19818-2"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2021.06.049"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/veaa098"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2103227"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.5607"},{"key":"B16","unstructured":"SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests. Available from: https:\/\/www.fda.gov\/medical-devices\/coronavirus-covid-19-and-medical-devices\/sars-cov-2-viral-mutations-impact-covid-19-tests"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6952"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.058"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/bs.aivir.2019.08.002"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-00845-3"},{"key":"B21","unstructured":"SARS-CoV-2 variant classifications and definitions. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/variants\/variant-classifications.html"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000515340"},{"key":"B23","unstructured":"Global Consultation on a Decision Framework for Assessing the Impact of SARS-CoV-2 Variants of Concern on Public Health Interventions. Available from: https:\/\/www.who.int\/news-room\/events\/detail\/2021\/03\/29\/default-calendar\/global-consultation-on-a-decision-framework-for-assessing-the-impact-of-sars-cov-2-variants-of-concern-on-public-health-interventions"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2020.11.005"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.04.438417"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-022-05612-6"},{"key":"B27","unstructured":"A Primer on Coronavirus, Variants, Mutation and Evolution. Available from: https:\/\/cals.ncsu.edu\/applied-ecology\/news\/a-primer-on-coronavirus-variants-mutation-and-evolution\/"},{"key":"B28","unstructured":"Natural selection vs creation: a literature review on the origin of SARS-CoV-2. Available from: https:\/\/www.infezmed.it\/media\/journal\/Vol_28_3_2020_3.pdf"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/covid2080080"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1220906"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11040875"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.1954"},{"key":"B33","unstructured":"SARS-CoV-2 variants of concern as of 15 March 2024. Available from: https:\/\/www.ecdc.europa.eu\/en\/covid-19\/variants-concern"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02240-21"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03426-1"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03470-x"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.03.002"},{"key":"B38","unstructured":"US Food and Drug Administration.   Fact sheet for health careproviders emergency use authorization (EUA) of bamlanivimaband etesevimab. Available from: https:\/\/www.fda.gov\/media\/145802\/download"},{"key":"B39","unstructured":"US Food and Drug Administration.   Fact sheet for health care providers emergency use authorization (EUA) of REGEN-COV (casirivimab with imdevimab). Available from: https:\/\/www.fda.gov\/media\/145611\/download"},{"key":"B40","unstructured":"US Food and Drug Administration.   Fact sheet for health careproviders emergency use authorization (EUA) of sotrovimab. Available from: https:\/\/www.fda.gov\/media\/149534\/download"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00068-9"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00628-0"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108891"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068848"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03402-9"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12060995"},{"key":"B47","unstructured":"COVID-19: Epidemiology, virology, and prevention. Available from: https:\/\/www.uptodate.com\/contents\/covid-19-epidemiology-virology-and-prevention"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02397-y"},{"key":"B49","unstructured":"SARS-CoV-2 Gamma variant. Available from: https:\/\/en.wikipedia.org\/wiki\/SARS-CoV-2_Gamma_variant"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/science.abh2644"},{"key":"B51","unstructured":"How Dangerous Is the Delta Variant (B.1.617.2)? Available from: https:\/\/asm.org\/Articles\/2021\/July\/How-Dangerous-is-the-Delta-Variant-B-1-617-2#:~:text=Data%20indicate%20that%20Delta%20is%2040-60%25%20more%20transmissible,airways%20of%20patients%20infected%20with%20the%20Delta%20variant."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28089-y"},{"key":"B53","unstructured":"Public Health England.   Investigation of novel SARS-CoV-2 variant: technical briefing. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/957504\/Variant_of_Concern_VOC_202012_01_Technical_Briefing_5_England.pdf"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01358-1"},{"key":"B55","unstructured":"Risk assessment for SARS-CoV-2 variant: Delta (VOC-21APR-02, B.1.617.2) Public Health England. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/991135\/3_June_2021_Risk_assessment_for_SARS-CoV-2_variant_DELTA.pdf"},{"key":"B56","unstructured":"Update on omicron-World Health Organization. 2021. Available from: https:\/\/www.who.int\/news\/item\/28-11-2021-update-on-omicron"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01911-2"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202112_27652"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.033"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/v14020294"},{"key":"B61","unstructured":"Ferguson N, Ghani A, Cori A, Hogan A, Hinsley W, Volz E on behalf of the Imperial College COVID-19 response team.   Imperial College London. Report 49 - Growth, population distribution and immune escape of the Omicron in England. Available from: https:\/\/www.imperial.ac.uk\/media\/imperial-college\/medicine\/mrc-gida\/2021-12-16-COVID19-Report-49.pdf"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.12.357"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00010-5"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.032"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27558"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00015-2"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119451"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2119270"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.043"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2895-3"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe8499"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.04.022"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.09.032"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-020-09954-3"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19808-4"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.11.026"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf2303"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.12.015"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.27124"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.14076"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-021-00496-8"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010951"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167058"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001237"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009286"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi9745"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.26.1.2002106"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61312"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.06.002"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03398-2"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108890"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.4388"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n359"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03412-7"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.02.003"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.01.014"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.13.426558"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-021-00954-4"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03324-6"},{"key":"B102","unstructured":"Genome Sequencing by INSACOG shows variants of concern and a Novel variant in India. Available from: https:\/\/pib.gov.in\/PressReleaseIframePage.aspx?PRID=1707177"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071542"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.025"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.06.006"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.751778"},{"key":"B107","unstructured":"How the coronavirus infects cells \u2014 and why Delta is so dangerous. Scientists are unpicking the life cycle of SARS-CoV-2 and how the virus uses tricks to evade detection. By Megan Scudellari. Available from: https:\/\/www.nature.com\/articles\/d41586-021-02039-y"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04266-9"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.12.456173"},{"key":"B110","unstructured":"How the coronavirus infects cells \u2014 and why Delta is so dangerous? Available from: https:\/\/www.nature.com\/articles\/d41586-021-02039-y"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.06.20248960"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2180-5"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27210"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27062"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.037"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00573-0"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.697035"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe5901"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3201\/eid2702.203794"},{"key":"B120","unstructured":"Fonager J.   Working paper on SARS-CoV-2 spike mutations arising in Danish mink, their spread to humans and neutralization data. Available from: https:\/\/files.ssi.dk\/Mink-cluster-5-short-report_AFO2"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010053"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0831"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.06.003"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.30.441434"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1451"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1101\/2020.12.24."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2852-1"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00556-5"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109292"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9302"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.02.042"}],"container-title":["World Journal of Methodology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2222-0682\/full\/v14\/i3\/89761.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2222-0682\/full\/v14\/i3\/89761.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T02:11:09Z","timestamp":1719281469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2222-0682\/full\/v14\/i3\/89761.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":131,"journal-issue":{"issue":"3"},"alternative-id":["89761"],"URL":"https:\/\/doi.org\/10.5662\/wjm.v14.i3.89761","relation":{},"ISSN":["2222-0682"],"issn-type":[{"value":"2222-0682","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,20]]}}}